Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: Evidence from a large international database

Journal of Clinical Oncology

Volumn 29, Issue 16, 2011, Pages 2178-2184

  Lorch, Anja ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Bascoul Mollevi, Caroline ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Kramar, Andrew ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Einhorn, Lawrence ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Necchi, Andrea ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Massard, Christophe ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   De Giorgi, Ugo ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Fléchon, Aude ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Margolin, Kim ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Lotz, Jean Pierre ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Germà Lluch, Jose Ramon ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Powles, Thomas ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Kollmannsberger, Christian ^{a,b,c,d,e,f,g,h,i,j,k,l,m}   Beyer, Jörg ^{a,b,c,d,e,f,g,h,i,j,k,l,m}  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b VIVANTES KLINIKUM AM URBAN   (Germany)

^c HÔPITAL TENON   (France)

^d CENTRE LÉON BÉRARD   (France)

^e CENTRE VAL D AURELLE   (France)

^f CENTRE OSCAR LAMBRET   (France)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

ⁱ INDIANA UNIVERSITY   (United States)

^j Seattle Cancer Center Alliance   (United States)

^k CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^l ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^m UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; THIOTEPA; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER GROWTH; CANCER PATIENT; DATA BASE; GERM CELL TUMOR; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; POPULATION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SALVAGE THERAPY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; HUMANS; IFOSFAMIDE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PACLITAXEL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; THIOTEPA; VINBLASTINE; YOUNG ADULT;

EID: 79957955963     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.6678     Document Type: Article

References (13)

1. Nichols CR, Tricot G, Williams SD, et al: Dose-intensive chemotherapy in refractory germ cell cancer: A phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7:932-939, 1989 (Pubitemid 19172468)
2. Siegert W, Beyer J, Strohscheer I, et al: High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: A phase I/II study - The German Testicular Cancer Cooperative Study Group. J Clin Oncol 12:1223-1231, 1994 (Pubitemid 24173937)
3. Loehrer PJ Sr, Gonin R, Nichols CR, et al: Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16:2500-2504, 1998 (Pubitemid 28309047)
4. Motzer RJ, Mazumdar M, Sheinfeld J, et al: Sequential dose-intensive paclitaxel, ifosfamide, carboplatin and etoposide salvage therapy for germ cell tumor patients. J Clin Oncol 18:1173-1180, 2000 (Pubitemid 30159833)
5. Beyer J, Stenning S, Gerl A, et al: High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: A matched-pair analysis. Ann Oncol 13:599-605, 2002 (Pubitemid 34461144)
6. Vaena DA, Abonour R, Einhorn LH: Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables. J Clin Oncol 21:4100-4104, 2003 (Pubitemid 46606176)
7. Kondagunta GV, Bacik J, Donadio A, at al: Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23:6549-6555, 2005 (Pubitemid 46190247)
8. Einhorn LH, Williams SD, Chamness A, et al: High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 357:340-348, 2007 (Pubitemid 47124134)
9. Pico JL, Rosti G, Kramar A, et al: A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours. Ann Oncol 16:1152-1159, 2005 (Pubitemid 41418319)
10. International Prognostic Factor Study Group, Lorch A, Beyer J, et al: Prognostic factors in patients with metastatic germ cell tumors who fail cisplatin-based first-line chemotherapy. J Clin Oncol 28:4906-4911, 2010
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
12. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
13. Lorch A, Neubauer A, Hackenthal M, et al: High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors. Ann Oncol 21:820-825, 2010